Journal of psychoactive drugs最新文献_第2页

The Epidemiology of Psychedelic Use Among United States Military Veterans. 美国退伍军人使用迷幻药的流行病学。

IF 2.2 4区医学

Journal of psychoactive drugs Pub Date : 2025-09-01 Epub Date: 2024-09-12 DOI: 10.1080/02791072.2024.2401977

Alan K Davis, Mark Bates, Erik M Lund, Nathan D Sepeda, Adam W Levin, Stacey B Armstrong, Robert Koffman, Katinka Hooyer, Rachel Yehuda

{"title":"The Epidemiology of Psychedelic Use Among United States Military Veterans.","authors":"Alan K Davis, Mark Bates, Erik M Lund, Nathan D Sepeda, Adam W Levin, Stacey B Armstrong, Robert Koffman, Katinka Hooyer, Rachel Yehuda","doi":"10.1080/02791072.2024.2401977","DOIUrl":"10.1080/02791072.2024.2401977","url":null,"abstract":"We sought to identify patterns of psychedelic use among United States military veterans, compare demographic variables and perspectives of those who did and did not report use, and characterize benefits and adverse outcomes associated with use. Respondents (N = 426) were recruited to complete an online cross-sectional survey. Approximately one-half (51%) reported using psychedelics. Most did so for healing/treatment (70%) and/or spiritual purposes (48%), and most (85%) reported benefiting from use. Those who used psychedelics reported they would be more likely to use VA services (p < .001, d = 0.64) and to return to the VA for care (p < .001, d = 0.79) if psychedelic therapy was offered. Almost two-thirds (59%) reported adverse outcomes associated with use. Equivalent proportions rated their psychedelic experiences as beneficial among those who did (89%) and did not (81%) report adverse outcomes. Fewer adverse outcomes were associated with being older, using psilocybin, feeling prepared and confident in the reasons for use, being in a comfortable setting, and being able to \"trust, let go, and be open\" (Rc = 0.77; p < .001). Psychedelics may offer benefits but may also lead to adverse outcomes without proper preparation and support. Future research should examine the utility of psychedelic-based approaches for veteran mental health care.","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"399-412"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289791","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Factors Associated with an Increased Risk of Opioid Misuse Among Patients with Non-Cancer Pain in Malaysian Pain Clinic Settings. 马来西亚疼痛诊所非癌症疼痛患者滥用阿片类药物风险增加的相关因素。

IF 2.2 4区医学

Journal of psychoactive drugs Pub Date : 2025-09-01 Epub Date: 2024-08-05 DOI: 10.1080/02791072.2024.2387602

Asween R Sani, Che Suraya Zin

{"title":"Factors Associated with an Increased Risk of Opioid Misuse Among Patients with Non-Cancer Pain in Malaysian Pain Clinic Settings.","authors":"Asween R Sani, Che Suraya Zin","doi":"10.1080/02791072.2024.2387602","DOIUrl":"10.1080/02791072.2024.2387602","url":null,"abstract":"This study examined the factors associated with a high risk of opioid misuse among patients receiving opioid treatment for their non-cancer pain in Malaysian pain clinics. The Screener and Opioid Assessment for Patients with Pain-Revised (SOAPP-R), a validated instrument for predicting the risk of aberrant drug-related behaviors, were used as a proxy to indicate risk of opioid misuse. Data analysis was stratified into high-risk and low-risk patient groups. Patient factors assessed included pain intensity, pain interference with daily activities, and health-related quality of life. Prescription opioid exposure was examined via patient medical and prescription records review. Among the 61 patients recruited, 62.3% scored ≥18 on the SOAPP-R, which indicates a high risk for opioid misuse. Factors associated with a high risk of opioid misuse were found to be high level of pain interference with daily activities, poorer mental health, and younger age. High-risk patients were found to be prescribed a lower mean daily opioid dose of <20 mg/day compared to low-risk patients (20-49 mg/day). This highlights the need for further research to distinguish aberrant drug-related behaviors due to inadequate pain management from that of actual prescription opioid misuse among non-cancer pain patients attending pain clinics.","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"444-454"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141889509","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Ethical Issues in Treating Substance Use Disorders: Counselor Perspectives. 治疗药物使用障碍的伦理问题：咨询师的观点。

IF 2.2 4区医学

Journal of psychoactive drugs Pub Date : 2025-09-01 Epub Date: 2024-08-30 DOI: 10.1080/02791072.2024.2394765

James L Sorensen, Caravella McCuistian, J Konadu Fokuo, Homero E Del Pino, Jaime Dumoit Smith, Sania Elahi, Emily A Arnold

{"title":"Ethical Issues in Treating Substance Use Disorders: Counselor Perspectives.","authors":"James L Sorensen, Caravella McCuistian, J Konadu Fokuo, Homero E Del Pino, Jaime Dumoit Smith, Sania Elahi, Emily A Arnold","doi":"10.1080/02791072.2024.2394765","DOIUrl":"10.1080/02791072.2024.2394765","url":null,"abstract":"Ethical issues arise frequently in the treatment of substance use disorders (SUD). Counselors need guidance to navigate ethical dilemmas but receive limited training in resolving ethical issues. To narrow the gap between the ethical dilemmas counselors face and their training, this qualitative study assessed ethical issues that counselors encounter, how they resolve them, and desired training. We conducted qualitative individual interviews with 20 front-line counselors working in two SUD treatment programs, presenting brief vignettes that depicted the ethics code of the national organization representing SUD counselors. The interviews asked open-ended questions about how counselors dealt with issues and their ideas for future ethics training. All participants had encountered ethical dilemmas. Areas of concern included confidentiality and privacy, mandatory reporting, fairness/equity, client-counselor boundaries, tensions between workplace and client welfare, and meeting clients' complex needs. Ways participants resolved ethical issues included consultations, using direct approaches to resolve ethical dilemmas, and commitment to providing client-centered care. Useful training in the workplace was sparse. Participants expressed needs for ongoing support to resolve workplace ethical dilemmas. Although the importance of ethical issues is widely acknowledged in treating SUD, this study underscores the need for ongoing and interactive training and supervision about ethical issues.","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"465-474"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11868449/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142108601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Effects of Cannabis Use on Neurocognition: A Scoping Review of MRI Studies. 吸食大麻对神经认知的影响：核磁共振成像研究范围综述》。

IF 2.2 4区医学

Journal of psychoactive drugs Pub Date : 2025-09-01 Epub Date: 2024-06-29 DOI: 10.1080/02791072.2024.2372377

Dima Audi, Shorouk Hajeer, Marie-Belle Saab, Lea Saab, Hayat Harati, Alban Desoutter, Elie Al Ahmar, Elias Estephan

{"title":"Effects of Cannabis Use on Neurocognition: A Scoping Review of MRI Studies.","authors":"Dima Audi, Shorouk Hajeer, Marie-Belle Saab, Lea Saab, Hayat Harati, Alban Desoutter, Elie Al Ahmar, Elias Estephan","doi":"10.1080/02791072.2024.2372377","DOIUrl":"10.1080/02791072.2024.2372377","url":null,"abstract":"Cannabis is one of the most commonly utilized recreational drugs. However, increasing evidence from the literature suggests harmful implications on cognition. Thus, the main aim of the current review is to summarize literature findings pertaining to the impact of cannabis on neurocognitive skills, focusing on the imaging biomarkers provided by MRI. Two reviewers navigated the literature independently using four main search engines including PubMed and Cochrane. Articles were first evaluated through their title and abstract, followed by full-text assessment. Study characteristics and findings were extracted, and the studies' quality was appraised. 47 articles were included. The majority of the studies were of a case-control design (66%), and the most studied neurocognitive skill was memory (40.4%). With task-based fMRI being the most commonly utilized MRI technique, findings have shown significantly varying decreased and increased neuronal activity within brain regions associated with the cognitive tasks performed. Results suggest that cannabis users are significantly suffering from cognitive deficits. The major significance of this review is attributed to highlighting the role of MRI. Future research needs to delve more into validating the negative effects of cannabis, to enable stakeholders to take action to limit cannabis usage, to foster public health and wellbeing.","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"357-373"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141468953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A Cross-Sectional Survey Investigating Māori and Non-Māori Cancer Patients' Views on Psychedelic-Assisted Therapy in Aotearoa New Zealand. 新西兰奥特亚罗瓦毛利人和非毛利人癌症患者对迷幻辅助疗法看法的横断面调查。

IF 2.2 4区医学

Journal of psychoactive drugs Pub Date : 2025-09-01 Epub Date: 2024-09-04 DOI: 10.1080/02791072.2024.2397427

Georgia Best, Eva Morunga, Alesha Wells, Jenny Allison, Lisa Reynolds

{"title":"A Cross-Sectional Survey Investigating Māori and Non-Māori Cancer Patients' Views on Psychedelic-Assisted Therapy in Aotearoa New Zealand.","authors":"Georgia Best, Eva Morunga, Alesha Wells, Jenny Allison, Lisa Reynolds","doi":"10.1080/02791072.2024.2397427","DOIUrl":"10.1080/02791072.2024.2397427","url":null,"abstract":"People with cancer experience higher rates of psychological dysfunction than the general population, with extreme inequity among indigenous people. Psychedelic-assisted therapy (PAT) is a reemerging area with promising evidence as a treatment for mental health difficulties. The current study aimed to investigate the perceptions of PAT in indigenous (Māori) and non-indigenous cancer patients in Aotearoa, New Zealand. Eighty-five cancer patients (Māori n = 32, non-Māori n = 53) completed a brief anonymous survey assessing demographics, psychological factors, and awareness and perceptions of PAT. Participants were recruited online (via social media and cancer support e-mail lists) and in person at Auckland City Hospital. Maori had significantly poorer psychological well-being than non-Māori. All participants had low awareness of this novel treatment and held largely neutral attitudes. Regression analyses revealed that predictors of more favorable attitudes toward PAT included greater awareness of psychedelics, advanced cancer stage, younger age, poorer holistic well-being, greater demoralization, and prioritizing treatment effectiveness over possible risks and uncertainty. The current study provides a foundational step in exploring perceptions toward PAT in indigenous and non-indigenous groups. These results have the potential to shape future research trials investigating PAT and further highlight the importance of indigenous involvement in the psychedelic research space.","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"431-443"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142126047","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Magic of the Mushrooms: Effects of Psilocybin Decriminalization. 蘑菇的魔力：迷幻药非刑罪化的影响。

IF 2.2 4区医学

Journal of psychoactive drugs Pub Date : 2025-09-01 Epub Date: 2024-07-10 DOI: 10.1080/02791072.2024.2376755

Ashutosh Bhave

{"title":"Magic of the Mushrooms: Effects of Psilocybin Decriminalization.","authors":"Ashutosh Bhave","doi":"10.1080/02791072.2024.2376755","DOIUrl":"10.1080/02791072.2024.2376755","url":null,"abstract":"In the past few years, psilocybin, a psychedelic compound found in \"magic mushrooms\" (psilocybin mushrooms), has undergone decriminalization in numerous cities across the US and has been legalized in Oregon and Colorado. Proponents of psilocybin decriminalization have emphasized its therapeutic potential in treating mental health disorders. Furthermore, psilocybin mushrooms are considered the safest psychedelic option, with lower potency and a reduced risk of overdoses and emergency hospitalizations compared to other prevalent psychedelics, such as LSD (lysergic acid diethylamide) and MDMA (3,4-methylenedioxymethamphetamine). We analyzed the impact of psilocybin reforms on public interest in psilocybin, as well as their cross-commodity effects on LSD and MDMA, utilizing extensive web-based search data. We observe a significant increase in psilocybin search volume and a notable reduction in search volume associated with LSD and MDMA. Our results are consistent nationwide across states, irrespective of their stance on psilocybin reforms. The shift in public interest toward psilocybin, which is considered the safest psychedelic, away from LSD and MDMA, carries positive implications for public health.","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"421-430"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141563586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts. 将个人迷幻体验作为促进者的培训资格：对迷幻剂专家定性访谈的主题分析。

IF 2.2 4区医学

Journal of psychoactive drugs Pub Date : 2025-09-01 Epub Date: 2024-09-13 DOI: 10.1080/02791072.2024.2401982

Ar Wilson-Poe, Ka Hoffman, K Pertl, Jb Luoma, A Bazinet, Cs Stauffer, D McCarty, Pt Korthuis

{"title":"Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts.","authors":"Ar Wilson-Poe, Ka Hoffman, K Pertl, Jb Luoma, A Bazinet, Cs Stauffer, D McCarty, Pt Korthuis","doi":"10.1080/02791072.2024.2401982","DOIUrl":"10.1080/02791072.2024.2401982","url":null,"abstract":"Emerging legal frameworks in Oregon and Colorado license facilitators to support adults receiving psychedelic services. The current legal frameworks are silent regarding facilitators' personal experience with psychedelics. An e-Delphi process recruited 36 experts with at least 5 years' experience facilitating psilocybin experiences in ceremonial settings, indigenous practices, or clinical trials. Respondents completed in-depth, semi-structured qualitative interviews via secure web links. Interviews were recorded, transcribed, and analyzed using Thematic Analysis. Experts with a mean of 15.2 (SD 13.1) years' experience providing psilocybin services expressed the importance of first-hand experience with psychedelics as a qualification for the emerging workforce. One participant questioned the necessity of personal psychedelic experience. Experts suggested that personal experience may indirectly support high-quality care because it enhances facilitators' personal wellbeing, and may help facilitators understand the complexity and nature of their clients' psychedelic experiences. Novel state-legal psychedelic paradigms create a real-world opportunity to assess associations between facilitators' personal psychedelic experience and the safety and outcomes of psychedelic services.","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"413-420"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Correlates of Current Methamphetamine Use and Opioid Co-Use Among Latina Women in a Low-Income Community. 低收入社区拉丁裔妇女目前使用甲基苯丙胺和共同使用阿片类药物的相关因素。

IF 2.2 4区医学

Journal of psychoactive drugs Pub Date : 2025-09-01 Epub Date: 2024-09-02 DOI: 10.1080/02791072.2024.2395494

J Frankeberger, T Perdue, E Ramirez, A Valdez, A Cepeda

{"title":"Correlates of Current Methamphetamine Use and Opioid Co-Use Among Latina Women in a Low-Income Community.","authors":"J Frankeberger, T Perdue, E Ramirez, A Valdez, A Cepeda","doi":"10.1080/02791072.2024.2395494","DOIUrl":"10.1080/02791072.2024.2395494","url":null,"abstract":"Using data from Proyecto SALTO, a 15-year follow-up study of a cohort of Mexican American women in a low-income community in San Antonio, Texas, this study examines emerging patterns of current methamphetamine (MA) use, including opioid co-use, among this understudied population. A bivariate analysis compared individuals with and without current MA use and identified sociodemographic correlates and co-occurring mental health and substance use. A secondary analysis compared those with current MA use, opioid use, and concurrent MA and opioid use. Nineteen percent of the sample had current MA use. MA use was associated with having a lower income (OR = 7.04-1.93, SE = 1.59-5.46), residential instability (OR = 5.19, SE = 1.99), and suicidal ideation (OR = 2.62, SE = 0.93). Participants with MA use had more than four times the odds of using opioids than those without MA use. Women with concurrent MA and opioid use differed in sociodemographics and behavioral risks compared to those with only MA or only opioid use. These findings explore the social, mental health, and structural inequities that exacerbate risks and harms associated with high-risk substance use among marginalized Latino populations. Prevention and intervention strategies should adopt a holistic approach that considers and addresses polysubstance use, mental health, and the sociocultural contexts in which individuals live.","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"455-464"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11872014/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142108600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Pharmacokinetics of Psilocybin, a Tryptamine Alkaloid in Magic Mushroom (Psilocybe cubensis): A Systematic Review. 神奇蘑菇（Psilocybe cubensis）中的一种色胺类生物碱--迷幻蘑菇素的药代动力学：系统综述。

IF 2.2 4区医学

Journal of psychoactive drugs Pub Date : 2025-09-01 Epub Date: 2024-09-10 DOI: 10.1080/02791072.2024.2399128

Nilubon Thaoboonruang, Manupat Lohitnavy, Ornrat Lohitnavy

{"title":"Pharmacokinetics of Psilocybin, a Tryptamine Alkaloid in Magic Mushroom (Psilocybe cubensis): A Systematic Review.","authors":"Nilubon Thaoboonruang, Manupat Lohitnavy, Ornrat Lohitnavy","doi":"10.1080/02791072.2024.2399128","DOIUrl":"10.1080/02791072.2024.2399128","url":null,"abstract":"Psilocybin, a major indole alkaloid found in magic mushrooms (Psilocybe cubensis), has recently drawn attention as a breakthrough therapy to treat major depressive disorder. This review aimed to summarize and identify knowledge gaps concerning their pharmacokinetic characteristics of psilocybin and its active metabolite, psilocin. Original studies related to pharmacokinetics of psilocybin conducted in vitro, animals, and humans were systematically collected from PubMed, Scopus, and ScienceDirect, from their inceptions to November 2023. Twenty articles were included in this work and assessed for study quality. A comprehensive review of the pharmacokinetics of psilocybin and psilocin in both animals and humans was performed. Psilocybin is considered a prodrug that is dephosphorylated to psilocin by alkaline phosphatase. Following ingestion, the peak psilocin plasma and brain levels were rapidly achieved in a dose-dependent manner. Psilocin is metabolized primarily through both Phase I and Phase II processes with the half-life of 2-3 hours. This review also identified lack of some pharmacokinetic related information and limitations of available research that may help direct future investigations to better understand the pharmacokinetics and improve study design including dose selection and dosage optimization.","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"386-398"},"PeriodicalIF":2.2,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142289789","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Role Strain Among Parents Who are Medical Cannabis Patients in Pennsylvania. 宾夕法尼亚州医用大麻患者父母的角色紧张

IF 2.2 4区医学

Journal of psychoactive drugs Pub Date : 2025-08-19 DOI: 10.1080/02791072.2025.2550293

Maddy Finkelstein, Elizabeth Salerno Valdez, Olivia Cordingley, Samantha Pagán, Janna Ataiants, Stephen E Lankenau

{"title":"Role Strain Among Parents Who are Medical Cannabis Patients in Pennsylvania.","authors":"Maddy Finkelstein, Elizabeth Salerno Valdez, Olivia Cordingley, Samantha Pagán, Janna Ataiants, Stephen E Lankenau","doi":"10.1080/02791072.2025.2550293","DOIUrl":"10.1080/02791072.2025.2550293","url":null,"abstract":"As medical cannabis legalization expands in the United States, more parents and people of child-bearing age are becoming medical cannabis patients (MCP). This analysis uses the theory of role strain to explore how parents navigate being an MCP in Pennsylvania. Twenty four semi-structured qualitative interviews with parents from an ongoing registry study of MCP were analyzed using an a priori codebook and complemented by codes to capture emergent themes. Additionally, memowriting was utilized to refine the analysis and validate findings. Parents described their cannabis use as supportive of their parental role through the reduction of physical and psychological symptoms, improvements to mood, and increased patience with children. However, participants also reported that fear of legal consequences and stigma around their medical cannabis use put strain on their role as parents. The MCP role both supports and strains the parental role depending on context and situation. Results indicate a need for more research among parents who are MCP, especially along lines of identity and factors such as race, and ethnicity.","PeriodicalId":16902,"journal":{"name":"Journal of psychoactive drugs","volume":" ","pages":"1-9"},"PeriodicalIF":2.2,"publicationDate":"2025-08-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144883086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0